Tim Moore
Price Movement Since Trade
How each stock has moved from the trade date to the most recent close.
Suspicious Timing Detected
4 flagsRep. Tim Moore sold $100K-$250K in Centene Corporation (CNC) on August 18, 2025 — 30 days before HJRES123, which aimed to disapprove a rule related to the Affordable Care Act's marketplace.
Rep. Tim Moore sold $50K-$100K in UnitedHealth Group (UNH) on August 15, 2025 — 83 days before S976, the Insurance Fraud Accountability Act, which would increase penalties for insurance fraud.
Rep. Tim Moore bought $15K-$50K in UnitedHealth Group (UNH) on August 8, 2025 — 85 days before a $782 million Department of Veterans Affairs contract was awarded to Optum Public Sector Solutions, Inc., a subsidiary of UnitedHealth Group.
Rep. Tim Moore sold $50K-$100K in UnitedHealth Group (UNH) on August 15, 2025 — 97 days before HR6166, the Lowering Drug Costs for American Families Act, which aims to reduce pharmaceutical company revenues.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $SMCY | Yieldmax Smci Optn Inc Strg ETF - SMCY [OT](ETF) | $100K-$250K | — | — | — | Aug 7, 2025 |
| BUY | $TZA | Direxion Daily Small Cap Bear 3X ETF - TZA [OT](ETF) | $50K-$100K | — | — | — | Aug 25, 2025 |
| BUY | $MSTY | Yieldmax MSTR Opt Incm Strtgy ETF (MSTY) [OT](ETF) | $50K-$100K | — | — | — | Aug 11, 2025 |
| BUY | $CNC | Centene Corporation Common Stock (CNC) [ST] | $15K-$50K | — | $41.09 | — | Aug 7, 2025 |
| BUY | $TZA | Direxion Daily Small Cap Bear 3X ETF - TZA [OT](ETF) | $15K-$50K | — | — | — | Aug 14, 2025 |
| BUY | $TZA | Direxion Daily Small Cap Bear 3X ETF - TZA [OT](ETF) | $15K-$50K | — | — | — | Aug 28, 2025 |
| BUY | $HY | Hyster-Yale, Inc. Class A common stock (HY) [ST] | $15K-$50K | — | — | — | Aug 12, 2025 |
| BUY | $HY | Hyster-Yale, Inc. Class A common stock (HY) [ST] | $15K-$50K | — | — | — | Aug 7, 2025 |
| BUY | $INTC | Intel Corporation - Common Stock (INTC) [ST] | $15K-$50K | — | — | — | Aug 8, 2025 |
| BUY | $INTC | Intel Corporation - Common Stock (INTC) [ST] | $15K-$50K | — | — | — | Aug 1, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Lowering Drug Costs for American Families Act
The Lowering Drug Costs for American Families Act (HR6166) expands Medicare drug negotiation from 20 to 50 drugs and extends inflation rebates to commercial markets, targeting bearish revenue compression for major pharma ($MRK, $PFE, $LLY). Health insurers ($UNH, $CVS) face mixed effects — lower drug costs offset by new out-of-pocket caps. The bill is in early committee stage, giving markets time to price in the structural shift.
ANCHOR Act of 2025
The ANCHOR Act of 2025 (S. 3300) creates a new state option to expand Medicaid eligibility to uninsured adults with serious mental illness or substance use disorder at or below 100% FPL. The bill is in early legislative stages—referred to Senate Finance Committee December 2025. Despite early status, the market is pricing in passage: CNC has rallied +62% in 30 days to $53.11, MOH +46% to $195.22, and HUM +39% to $241.35. Centene, Molina, and Humana are the primary structural beneficiaries due to their outsized Medicaid MCO exposure.
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $782M Department of Veterans Affairs Contract
This $782 million contract for EXPRESS REPORT services awarded to Optum Public Sector Solutions, Inc. is a significant win for parent company UnitedHealth Group ($UNH), bolstering its government healthcare technology segment and aligning with legislative efforts to improve healthcare services.
Medical Nutrition Therapy Act of 2025
Bipartisan bill to expand Medicare MNT coverage to obesity, cancer, eating disorders, and HIV/AIDS — currently in early House committee stage with 17 cosponsors and a companion Senate bill. Expands the addressable market for nutrition therapy services within Medicare by 3-5x. UNH and CVS stand to benefit from increased patient volume in their integrated care and pharmacy networks, though passage is not guaranteed in 2026.
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Patient Protection and Affordable Care Act; Marketplace Integrity and Affordability".
H.J.Res.123 would nullify a CMS rule that tightened Marketplace enrollment integrity. The bill is early stage (referred to committee) but has a failed companion in the Senate. Market pricing in $CNC and $MOH has been extremely bullish (+63% and +46% over 30 days) based on broader momentum, not this legislative risk. If the resolution gains traction, it creates downside risk for pure-play ACA insurers.
Increasing Access to Lung Cancer Screening Act
HR6178, introduced in November 2025 and referred to two committees, mandates no-cost lung cancer screenings and expanded tobacco cessation services under Medicaid, Medicare, and private insurance. This creates a direct revenue tailwind for diagnostic lab companies $LH and $DGX through increased test volume, and a pharmacy/PBM benefit for $CVS through mandated tobacco cessation drug coverage. Health insurers ($UNH, $HUM, $CNC, $MOH) face a neutral cost burden from the coverage mandate and prior authorization ban, with manageable MLR impact given the preventive nature of the service. The bill is early-stage with no appropriation attached.
OPTUM PUBLIC SECTOR SOLUTIONS, INC.: $895M Department of Veterans Affairs Contract
This $895 million Department of Veterans Affairs contract to Optum Public Sector Solutions, Inc., a subsidiary of UnitedHealth Group ($UNH), is bullish for the company. It represents a significant revenue stream in the healthcare technology sector, reinforced by legislative support for healthcare services.
Insurance Fraud Accountability Act
The Insurance Fraud Accountability Act (S.976) imposes new $10k–$50k civil penalties per violation on agents/brokers for fraudulent ACA enrollments. Though still in early committee stage, the bill places compliance burdens on major health insurers operating ACA marketplaces. Recent 30-day rallies of +36% in UNH and +39% in HUM appear disconnected from this specific regulatory risk, suggesting potential sector downside as legislative risk is repriced.
Foreign Robocall Elimination Act
The Foreign Robocall Elimination Act (S. 2666) is a procedural authorization bill establishing an interagency taskforce on unlawful robocalls. No new funding is authorized, but the bill mandates increased cybersecurity and analytics investment by telecom carriers. Pure-play cybersecurity firms $CRWD, $PANW, and $FTNT have seen strong 30-day gains of +12.54%, +9.86%, and +2.13% respectively, reflecting broad sector momentum. The bill is still awaiting floor action after passing committee, adding timing uncertainty.
Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025
HR5199 is an early-stage bill that would allow PAs and NPs to practice independently in rural non-physician-directed clinics under State law, removing a federal Medicare supervision requirement. The bill authorizes zero funding and has a distant effective date of January 2027. For insurers like UNH, CNC, and CI, and hospital operator HCA, the impact is modest — a small reduction in rural facility costs that won't materially move earnings.
Other Filings by Tim Moore
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.